Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Withdrawn × Denosumab × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Completed 13 Terminated 7 Unknown 3 Withdrawn 1 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 51 Radiotherapy 47 Cisplatin 40 Paclitaxel 39 Gemcitabine 39 Cyclophosphamide 37 Carboplatin 35 Dexamethasone 32 Nivolumab 31 Docetaxel 31 Fluorouracil 29 Bevacizumab 28 Oxaliplatin 27 durvalumab 25 Magnetic Resonance Spectroscopy 24 Leucovorin 23 Rituximab 22 Capecitabine 21 Pemetrexed 20 Drug Therapy 18 atezolizumab 17 Radiosurgery 17 Doxorubicin 17 Cytarabine 17 Radiation 16 Bortezomib 16 Prednisone 15 Etoposide 15 fludarabine 13 Lenalidomide 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03532087 2020-01-18

PERIDENO

Borstkanker Onderzoek Groep

Phase 2 Withdrawn

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡